Detalhe da pesquisa
1.
Risk factors for difficult-to-treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub-Saharan Africa.
J Viral Hepat
; 28(4): 682-686, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421247
2.
Improved quality of life following direct-acting antiviral treatment for chronic hepatitis C infection in Rwanda: Results from a clinical trial in sub-Saharan Africa (the SHARED study).
J Viral Hepat
; 28(1): 112-120, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32858774
3.
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.
BMC Public Health
; 20(1): 946, 2020 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546216
4.
Rwanda launches a 5-year national hepatitis C elimination plan: A landmark in sub-Saharan Africa.
J Hepatol
; 70(6): 1043-1045, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948269
5.
Safety and efficacy of sofosbuvir-velpatasvir-voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial.
Lancet Gastroenterol Hepatol
; 7(6): 542-551, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248212
6.
Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa.
Lancet Gastroenterol Hepatol
; 7(11): 1036-1048, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35810766
7.
Care seeking and treatment for hepatitis C infection in Rwanda: A qualitative study of patient experiences.
Glob Public Health
; 15(12): 1778-1788, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735478
8.
Safety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda.
Hepatol Commun
; 4(4): 569-576, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32258951
9.
Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial.
Lancet Gastroenterol Hepatol
; 4(2): 119-126, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552056
10.
"Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.
PLoS One
; 12(3): e0174148, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28323868
11.
Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030.
Lancet Gastroenterol Hepatol
; 2(12): 910-919, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132760
12.
Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets.
Lancet Gastroenterol Hepatol
; 2(12): 900-909, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132759
13.
Five-Year Antimicrobial Susceptibility Trends Among Bacterial Isolates from a Tertiary Health-Care Facility in Kigali, Rwanda.
Am J Trop Med Hyg
; 95(6): 1277-1283, 2016 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27799637
14.
Hepatitis C treatment outcomes using interferon- and ribavirin-based therapy in Kigali, Rwanda.
Trans R Soc Trop Med Hyg
; 110(8): 495-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27618922
15.
Association of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women.
AIDS Res Hum Retroviruses
; 31(7): 723-30, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25924728
16.
Over-reported peripheral neuropathy symptoms in a cohort of HIV infected and uninfected Rwandan women: the need for validated locally appropriate questionnaires.
Afr Health Sci
; 14(2): 460-7, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25320598